Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction

This publication has 18 references indexed in Scilit:

• Unaltered perception of dyspnoea during treatment with long-acting β₂-agonists
  European Respiratory Journal, 2001
• Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists
  Thorax, 2001
• Onset of Bronchodilation of Budesonide/Formoterol vs. Salmeterol/Fluticasone in Single Inhalers
  Pulmonary Pharmacology & Therapeutics, 2001
• Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study
  European Respiratory Journal, 2000
• Comparison of the Relative Efficacy of Formoterol and Salmeterol in Asthmatic Patients
  American Journal of Respiratory and Critical Care Medicine, 1999
• Comparison of formoterol, salbutamol and salmeterol in methacholine-induced severe bronchoconstriction
  European Respiratory Journal, 1999
• Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency
  European Respiratory Journal, 1997
• Lung volumes and forced ventilatory flows
  European Respiratory Journal, 1993
• A comparison of the visual analogue scale and modified Borg scale for the measurement of dyspnoea during exercise
  Clinical Science, 1989
• Statement on Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease (COPD) and Asthma
  American Review of Respiratory Disease, 1987